Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)
Clinical trial NCT01694849 · COMPLETED
Trial details
- NCT number
- NCT01694849
- Sponsor
- Genfit
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2015-02-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.